Giant Cell Arteritis — SCE Neurology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — Start long-term relapse-prevention immunotherapy after specialist counselling
AQP4-positive NMOSD is highly relapse prone and attacks commonly leave major disability, so long-term preventive immunotherapy is generally started after the first attack. Waiting for recurrence is unsafe. MS platform drugs such as interferon beta or glatiramer are ineffective and can worsen disease; intermittent steroid pulses are not an adequate sole maintenance strategy.
Reference: NEMOS 2023 recommendations for NMOSD attack therapy and long-term management (Published 2023): https://pmc.ncbi.nlm.nih.gov/articles/PMC10770020/